Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
European Radiology|May 21, 2008
Coronary revascularization treatment based on dual-source computed tomographyR Dikkers, T P Willems, L H Piers, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 7, 2007
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational studyC A Geluk, R A Tio, J G P Tijssen, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 6, 2018
Long-term prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteriesAndrea G Monroy-Gonzalez, R A Tio, J C de Groot, et al.Gene Therapy|February 22, 2002
Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aortaA J M Roks, R H Henning, H Buikema, et al.Clinical Biochemistry|July 15, 2009
The diagnostic value of soluble CD163 in patients presenting with chest painH M Willemsen, I C C van der Horst, W Nieuwland, et al.Biomaterials|October 4, 2002
Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-culturesM J A van Luyn, R A Tio, X J Gallego y van Seijen, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 21, 2010
Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathyR A Tio, R H J A Slart, R A de Boer, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 19, 2022
COVID-19-mediated patient delay caused increased total ischaemic time in ST-segment elevation myocardial infarctionH N Sturkenboom, V A E van Hattem, W Nieuwland, et al.Disease Markers|January 6, 2011
Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?J J W Verschuren, M L Sampietro, D Pons, et al.Human Gene Therapy|June 17, 2006
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trialY H Kusumanto, V van Weel, N H Mulder, et al.Pageof 9